Jackson Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AWA
Jackson Wealth Management's PFE Position: Q4 2022 in Review
Jackson Wealth Management sold out of Pfizer (PFE) in Q4 2022, closing a stake of 52,612 shares — an estimated $2.3M sold.
Jackson Wealth Management first reported a position in PFE in Q2 2015 and held it in 22 quarters. The position peaked at $3.36M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Jackson Wealth Management reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
- Jackson Wealth Management sold 52,612 Pfizer shares in Q4 2022, an estimated $2.3M.
- Jackson Wealth Management first reported a position in Pfizer in Q2 2015 and held it in 22 quarters.
- Jackson Wealth Management's Pfizer position peaked at $3.36M in Q4 2021.
- 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Jackson Wealth Management's 13F filing for Q4 2022, filed 10 Feb 2023.